The QualityStocks Daily Tuesday, May 22nd, 2018

Today's Top 3 Investment Newsletters

StockMarketWatch (CHEKW) +93.50%

QualityStocks (VGID) +45.45%

NetworkNewsWire (PRVCF) +34.38%

The QualityStocks Daily Stock List

Rainforest Resources, Inc. (RRIF)

Stockopedia, High Rising Stocks, Stockflare, Investing News Alerts, Wall Street Pennies, Penny Stock Hub, Simply Wall St, Barchart, MarketWatch, Stockhouse, InvestorsHub, 4-Traders, TradingView, YCharts, Wallmine, OTC Markets, and WalletInvestor reported on Rainforest Resources, Inc. (RRIF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Rainforest Resources, Inc.’s corporate mission is to protect the ecosystems of the rainforest to lessen the impact of global warming. As part of the Company’s dedication to prevent global warming, it is making the best of efforts to preserve the rainforest, the initial phase being the “Huamboya Forest” Morona Santiago – Ecuador.

The Company previously went by the name Amalgamated Gold & Silver, Inc. It changed its name to Rainforest Resources, Inc. in December of 2015. The Company’s shares trade on the OTC Markets Group’s OTCQB. Rainforest Resources has its U.S. office in Anna Maria, Florida. The Company also has an office in Ecuador and a Singapore representative office.

Rainforest Resources operates in the forestry sector. In addition, the Company produces carbon credit certificates; and also develops and exports natural spring water. Rainforest Resources, in its devotion to ease global warming, dedicates all its efforts and economic support for the conservation of the humid forest.

Rainforest Resources is interested in conserving the Huamboya ecosystem. Huamboya presents a Humid Tropical Megathermal climate. The forest is covered by native forest without human intervention.

The Huamboya forest has approximately 586 endemic plant species of which 45 percent are orchids. The forest has a rich diversity of animal life. This includes 343 species of birds, 100 species of mammals, and greater than 500 species of vertebrates.

Rainforest Resources’ positions are in tropical rain forests, land for reforestation, and above all clean air. In essence, the Company’s vision is to sustain forestry as well as to live in harmony with forestry in itself.

Huamboya means Huambu: floating and Ya: house in the old Shuar language. "The house that floats" is inhabited by "SHUAR" communities including the Namakim and Chiguaza that are part of the Sangay National Park situated specifically to the South-East of the reserve. At Huamboya, millenary trees and endemic species of the Amazon, terrestrial, aquatic, as well as aerial are found.

Rainforest Resources, Inc. (RRIF), closed Tuesday's trading session at $6.30, up 14.55%, on 704 volume with 6 trades. The average volume for the last 60 days is 1,186 and the stock's 52-week low/high is $1.00/$9.45.


Rise Gold Corp. (RYES)

StockChase, MarketWatch, Marketwired, Stockhouse, 4-Traders, OTC Markets, and Streetwise Reports reported on Rise Gold Corp. (RYES), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Rise Gold Corp. is an exploration-stage mining company listed on the OTC Markets Group’s OTCQB. The Company’s main asset is the historic past producing Idaho-Maryland Gold Mine located in the State of California. The Idaho-Maryland Mine was a significant past producer, yielding 2.4M oz of gold. Rise Gold has its head office in Vancouver, British Columbia.

There are manifold exploration targets today on the Idaho-Maryland Gold Mine property that is fully owned by Rise Gold. This includes surface and mineral rights. The Company owns all the mineral rights and there are no royalties on this private land. This Mine is near Grass Valley, California.

The Idaho-Maryland Gold Mine produced a total of 2,414,000 oz gold with an average mill head grade of 0.50oz/ton (approximately 17g/t). The Mine was producing up to 129,000 oz gold annually before being forced to shut down by the U.S. government in 1942. During WW II the U.S. War effort wanted to shut down precious metals excavation and shift the national mining workforce from gold to copper production.

This past September, Rise Gold announced that it negotiated an extension of the remaining payment due for the purchase of the 82-acre parcel of M-1 Industrial land neighboring the historic New Brunswick mine shaft in Nevada County, California. The extension of the payment terms will allow Rise Gold to center its financial resources on the exploration drill program at the Idaho-Maryland Gold Project.

The Mill Site property is directly adjacent to the Brunswick Mine shaft. This is where Rise Gold currently owns 37 acres of surface land. The Company’s belief is that the land purchase is a valuable addition to the Idaho-Maryland Gold Project.

In October, Rise Gold announced that exploration core drilling from surface began at the Idaho-Maryland Gold Project in Nevada County, California. The initial exploration drill hole was collared and cased to bedrock. Moreover, the rock core is now being logged.

The initial drill hole will drill through the Brunswick "Porphyrite" Block. It ends in the surrounding serpentinite that hosts the Idaho mineralization. The expectation is that the first hole will pierce several Brunswick style gold-quartz veins and stock-work zones.

Rise Gold Corp. (RYES), closed Tuesday's trading session at $0.08, up 1.78%, on 20,000 volume with 1 trade. The average volume for the last 60 days is 36,255 and the stock's 52-week low/high is $0.0699/$0.25.


Marathon Gold Corporation (MGDPF)

Streetwise Reports, Barchart, Penny Stock Hub,, Capital Equity Review, OTC Markets, Stockhouse, 4-Traders, TipRanks, MarketWatch, TradingView, The Street, Resource World, WalletInvestor,, Stockwatch, YCharts, Marketbeat, and Investors Hangout reported on Marathon Gold Corporation (MGDPF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A gold exploration Company, Marathon Gold Corporation is rapidly advancing its 100 percent owned Valentine Lake Gold Camp located in Newfoundland. At present, the Valentine Lake Gold Camp hosts four near-surface, primarily pit-shell constrained deposits with measured and indicated resources totaling 2,137,400 oz. of gold at 1.99 g/t and inferred resources totaling 1,104,700 oz. of gold at 1.99 g/t. The majority of the resources occur in the Marathon and Leprechaun deposits that also have resources below the pit shell.  Both deposits are open to depth and on strike. Marathon Gold has its head office in Toronto, Ontario.

The Valentine Lake Gold Camp is accessible by year-round road. It is in close proximity to Newfoundland’s electrical grid. Marathon maintains a 50-person all-season camp at the property. Recent metallurgical tests have demonstrated 93 percent to 98 percent recoveries through conventional milling and 50 percent to 70 percent recoveries through low cost heap leaching at the Leprechaun and Marathon Deposits.

Drilling this year will continue to center on expanding the Marathon Deposit at surface and to depth and also exploration drilling along the boggy covered area between the Marathon and Sprite Deposits.

Gold mineralization has been traced down more than 350 meters vertically at Leprechaun and close to a kilometer at Marathon. The four deposits outlined so far occur over a 20-kilometer system of gold bearing veins. Much of the 24,000-hectare property has had little detailed exploration activity to date.

Marathon Gold’s exploration projects include Baie Verte (100 percent owned -
Newfoundland) and the Bonanza Mine (100 percent owned – Oregon).

At the beginning of May, Marathon Gold announced that it established a new Mineral Resource Estimate for the Marathon Deposit at its Valentine Lake Property prepared under the direction of John T. Boyd Company in accordance with National Instrument 43-101 (NI 43-101). The resources were revised as part of the soon to be released Preliminary Economic Assessment (PEA).

All the gains came from the Marathon Deposit that was updated as of March 5, 2018. Because the pits were too small and require more drilling Sprite was not included in the PEA study.

Last week, Marathon Gold announced the first-rate results of an independent PEA on its Valentine Lake Gold Camp, central Newfoundland. The PEA provides a base case assessment of developing the Valentine Lake Gold Camp mineral resource through open pit mining, and gold recovery by a combination of a milling circuit and heap leaching, incorporating gravity and flotation circuits with leaching of the concentrate and tails.

Marathon Gold Corporation (MGDPF), closed Tuesday's trading session at $0.758, down 4.77%, on 78,012 volume with 35 trades. The average volume for the last 60 days is 42,515 and the stock's 52-week low/high is $0.6538/$1.14.


Bionik Laboratories Corp. (BNKL)

MarketWatch, Stockhouse, and OTC Markets reported on Bionik Laboratories Corp. (BNKL), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Bionik Laboratories Corp. is a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home. Through the acquisition of Interactive Motion Technologies, the Company has added a portfolio of products centered on upper and lower extremity rehabilitation of stroke patients. It fully integrated Interactive Motion Technologies, Inc. into the Company following the May 2016 acquisition.

Bionik Laboratories lists on the OTC Markets Group’s OTCQB. Established in 2010, the Company is based in Toronto, Ontario.

Bionik Laboratories has three products available on the market and three products in different stages of development. The design of the InMotion Systems - the InMotion ARM™, InMotion WRIST™, InMotion HAND™ and InMotion ANKLE™, are to provide intelligent, patient-adaptive therapy in a manner that has been clinically verified to maximize neuro-recovery.

The InMotion ARM is an evidence based intelligent, interactive rehabilitation technology. It senses patient movements and limitations, providing assistance-as-needed™ in real-time.

The InMotion HAND is an add-on module to be used with the InMotion ARM™. These two work in tandem to provide assist-as-needed™ support for reaching with grasp and release movements, or independently for focused training on individual hand movements.

The InMotion WRIST is an evidence based and research proven interactive rehabilitation device. InMotion WRIST senses patient movements and limitations. Moreover, it provides assistance-as-needed™. It can accommodate the range of motion of a normal wrist in daily tasks. InMotion WRIST can be used by clinicians as a stand-alone treatment option or in addition to the InMotion ARM.

Bionik Laboratories is also developing a lower-body exoskeleton, ARKE™. The design of ARKE™ is to allow paraplegics and other wheelchair users the ability to rehabilitate via walking.

Yesterday, Bionik Laboratories announced the launch of its improved InMotion Arm interactive robotic system for clinical rehabilitation of stroke survivors and those with mobility impairments because of neurological conditions. The improved new generation InMotion Arm will provide the same unique active-assisted robotic therapy. It will do so however with a new industrial design, which is modern, smaller, as well as sleeker. The software interface was completely redesigned to permit greater ease of use and as a result decreased training requirements for clinical staff.

Bionik has already sold and placed units of its new generation InMotion Arm system with rehabilitation hospitals. These include Saint Luke's South Hospital in Overland Park, Kansas and Bacharach Institute for Rehabilitation in Pomona, New Jersey.

Bionik Laboratories Corp. (BNKL), closed Tuesday's trading session at $0.06, up 9.09%, on 23,022 volume with 16 trades. The average volume for the last 60 days is 68,224 and the stock's 52-week low/high is $0.055/$0.40.


Cannabics Pharmaceuticals, Inc. (CNBX)

Stockgoodies, Promotion Stock Secrets, Cannabis Financial Network News, Market Intelligence Center, Wealth Insider Alert, Wall Street Mover, SmallCapVoice, StreetAuthority Daily, Wall Street Daily, TopPennyStockMovers, and TheMicrocapNews reported previously on Cannabics Pharmaceuticals, Inc. (CNBX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Cannabics Pharmaceuticals, Inc.’s devotion is to the development of advanced cannabinoid-based treatments and therapies. Its main emphasis is the development of novel therapies and biotechnological tools designed to provide relief from assorted ailments and treat human malignancies. The Company’s vision is to create individually tailored natural therapies for cancer patients, employing advanced screening systems and personalized bioinformatics tools. OTCQB-listed, Cannabics Pharmaceuticals has its headquarters in Bethesda, Maryland.

Cannabics has licensed Research and Development (R&D) based in Israel. This R&D’s commitment is to the development of palliative and personalized anti-cancer treatments channelling the multipurpose therapeutic values of cannabinoids to create tailored therapies for cancer patients. The Company’s integrated technology has created a successful medically standardized delivery system providing patients natural, reliable, and safe therapy.

Cannabics Pharmaceuticals’ advanced tools include novel delivery systems, personalized medicine diagnostics, and therapies based on cannabinoid compounds. Its chief technology is Cannabics SR. This technology is for a long acting oil capsule, which provides a safe, effective, and reliable administration of cannabis. The technology’s composition is exclusively from food grade materials.

In July 2017, Cannabics Pharmaceuticals announced that it executed a Collaboration Agreement with SIMFO GmbH. Under this Agreement, Cannabics shall be the exclusive worldwide provider of SIMFO's CTC diagnostics to cancer patients treated with natural cannabinoids. SIMFO (located in Germany) is an international leader in cancer diagnostics and liquid biopsies.

Cannabics Pharmaceuticals has established a Genetic lab. This lab will develop diagnostic tools based on human genome, tumor genetics, and cannabinoids.

This past November, Cannabics Pharmaceuticals announced that it filed the first of a cluster of patent applications with the US Patent & Trademark Office (USPTO) that covers their continuing work on the use of cannabinoid products for adjusting the varied microbial populations that live on and in the body.

Furthermore, in November, Cannabics Pharmaceuticals announced that it received a new research license from the Israeli Ministry of Health for the Characterization of anti-tumor activity of cannabinoids. The new license will enable Cannabics to continue its vision of developing an ecosystem for the creation of diagnostic tools and bringing to market diagnostic services for cancer patients who are medicated with cannabis.

Last month, the Company announced that it filed a global patent application with the PCT authorities on methods for testing which cannabinoids or combinations of cannabinoids are likely be effective in individual patients. The determination is made by testing the effects of cannabinoids on CTCs (Circulating Tumor Cells) and biopsies of cancer patients.

Cannabics Pharmaceuticals, Inc. (CNBX), closed Tuesday's trading session at $1.04, up 0.98%, on 94,976 volume with 122 trades. The average volume for the last 60 days is 168,698 and the stock's 52-week low/high is $0.60/$2.99.


Freedom Leaf, Inc. (FRLF)

Promotion Stock Secrets, CFN Media Group, SmallCapVoice, and StocksToBuyNow reported on Freedom Leaf, Inc. (FRLF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Freedom Leaf, Inc. (The Marijuana Legalization Company™) is a group of global, vertically integrated hemp businesses and cannabis media companies. It is a foremost go-to resource in the cannabis, medical marijuana, and industrial hemp industry. Freedom Leaf is building a varied portfolio of valuable businesses via strategic mergers, acquisitions, and acceleration projects across the industry. Freedom Leaf is based in Las Vegas, Nevada. Leafceuticals, Inc. is a wholly-owned division of Freedom Leaf.

The Company engages in mergers and acquisitions (M&A’s) in the marijuana industry. This includes incubation/acceleration and spin offs of new marijuana/hemp related companies. Freedom Leaf does not handle, grow, sell, or disperse marijuana.

Freedom Leaf targets acquisitions of high growth and niche companies. Its strategy is to identify select technology companies and companies that are involved in cannabis and industrial hemp genetics, intellectual property (IP), bioscience, nutraceutical, and pharmaceutical product development.

The Company’s flagship publication is Freedom Leaf Magazine, The Good News in Marijuana Reform. Freedom Leaf produces a portfolio of news, print, and digital multi-media verticals, websites, and web advertising, for the ever-developing and changing cannabis, medical marijuana, and industrial hemp industry. The content Freedom Leaf produces and curates principally attracts industry professionals.

Freedom Leaf earlier acquired This is the Spanish Speaking community's leading cannabis website. As part of this acquisition, Freedom Leaf acquired This is the largest Medical Cannabis information website in Spanish.

Hempology® is Freedom Leaf’s exclusively branded product line. Hempology® is now vertically integrated from seed to consumer, processing CBD and a complete spectrum of whole-hemp extracts for the entourage-effect. In addition, Freedom Leaf has its hemp-based rolling paper company, Plants to Paper.

This past January, Freedom Leaf reported that it fully acquired 100 percent of Green Market Europe S.L. (GME). GME is a Spanish producer of hemp products. Its facilities include a 21,000 sq. ft. light deprivation greenhouse, a 43,000 sq. ft. indoor growing research facility, and greater than 200 acres of outdoor production space.

In April, Freedom Leaf announced that it consummated its earlier-announced acquisition of the Irie CBD Product Line. This includes virtually all assets, trademarks, formulating equipment, formulas and products. Irie is a California-based CBD, "Cannabidiol", product line. It formulates, manufactures and distributes CBD tinctures, CBD edibles, CBD topicals and CBD concentrates to retail markets throughout the nation.

Today, Freedom Leaf announced it purchased a 25 percent equity interest in Cicero Transact, an invitation-only online community committed to building strategic business alliances and a solid method of transacting business. Cicero Transact is a new, exclusive platform. It brings together start-ups, entrepreneurs, companies, venture capital, and private equity firms to facilitate joint ventures (JVs), strategic partnerships, product and service transactions, mergers and acquisitions (M&As).

Freedom Leaf’s intention is to work with Cicero Transact concerning deals related to the cannabis and industrial hemp industry and other areas that can boost revenue. A soft launch of the Cicero Platform will take place in August of this year with a full launch soon after.

Freedom Leaf, Inc. (FRLF), closed Tuesday's trading session at $0.2002, down 10.63%, on 814,006 volume with 191 trades. The average volume for the last 60 days is 629,376728 and the stock's 52-week low/high is $0.0265/$0.4719.


Heliospectra AB (publ) (HLSPY)

Barchart,, MarketWatch and OTC Markets reported on Heliospectra AB (publ) (HLSPY), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Heliospectra AB (publ) specializes in intelligent lighting technology for plant research and greenhouse cultivation. The Company designs, develops, manufactures, and sells lighting systems in Sweden and around the world. Heliospectra is a global leader in intelligent lighting technology for horticulture controlled environments. The Company is based in Gothenburg, Sweden.

Heliospectra’s lighting system provides an effective and durable technology for cultivating greenhouse and indoor plants through uniting manifold different groups of versatile Light Emitting Diodes (LEDs) with optics, remote sensing techniques, and a strong heat dissipation solution. The Company provides smarter LED grow lights for commercial greenhouses, indoor grow facilities, and research applications.

Heliospectra’s patented solution enables growers to create customized lighting spectrum recipes. These recipes may be able to shorten a cannabis plant’s flowering cycle and even alter a strain’s balance of active cannabinoids.

The design and engineering of the Company’s highly-engineered Heliospectra Light System is to replace traditional lighting solutions in commercial greenhouse environments. For indoor grow facilities, its patented lighting system enables an operation to grow plants that look and taste better, have a longer shelf life, and increase the overall yield of its operation.

Heliospectra’s LED light systems make it possible to closely control the intensity of light wavelengths and to accurately match the spectrum to a particular plant. The spectral distribution of its systems (400nm to 735nm) is consistent with the action spectrum of photosynthesis and critical photomorphological receptors.

This past November, Heliospectra AB announced it was changing the name of the earlier announced light control software CORTEX to HelioCORE™, effective November 16, 2017. The new control system was introduced in July of 2017. It will be available for commercial sales during this Q1 2018. HelioCORE connects the Company’s LX60 adjustable spectra and LX50 high voltage intelligent LED lighting solutions with sensors and schedule functions for real-time light adjustments.

Furthermore, in November, Heliospectra announced that the Company was ranked the second-fastest growing technology company in Deloitte's prestigious Sweden Technology Fast 50. The Sweden Technology Fast 50 ranking includes public and private companies, large and small, in all areas of technology. The basis of the award is on Revenue growth over the last four years. Heliospectra came second with Revenue growth of 4 643 percent.

Last month, Heliospectra announced an order from a value-added reseller for a customer building a high-performance medicinal cannabis cultivation facility in Eastern Canada. The order for the Heliospectra LX60 intelligent LED lighting solution is valued at USD $651,200.

Heliospectra will demonstrate its intelligent lighting solutions, technical services, and new HelioCORE light control software at the upcoming Fruit Logistica event in hall 8.1 booth #B-16, February 7-9, 2018 in Berlin, Germany.

Heliospectra AB (publ) (HLSPY), closed Tuesday's trading session at $0.8751, up 4.16%, on 4,497 volume with 8 trades. The average volume for the last 60 days is 7,404 and the stock's 52-week low/high is $0.3809/$1.20.


Northwest Biotherapeutics, Inc. (NWBO)

PureActionStocks, Pennybuster, The Street, FeedBlitz, AllPennyStocks, BullRally,, InvestorPlace, Promotion Stock Secrets, RedChip, Wall Street Corner, BUYINS.NET, WealthMakers, Wealthpire, CoolPennyStocks, StreetInsider, StockPicksNYC, Market Report, Streetwise Reports, OTCPicks, and SmallCapVoice reported previously on Northwest Biotherapeutics, Inc. (NWBO), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Northwest Biotherapeutics, Inc. is a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers. In the U.S. and Europe, its emphasis is on developing personalized immunotherapy products, on a cost-effective basis, designed to treat cancers more effectively than existing treatments. This is without toxicities of the type associated with chemotherapies. OTCQB-listed, Northwest Biotherapeutics is based in Bethesda, Maryland.

Northwest Biotherapeutics has an extensive platform technology for DCVax dendritic cell-based vaccines. It is working to move ahead with numerous clinical programs, involving DCVax-L and DCVax-Direct.

The Company’s lead program is a 331-patient Phase III trial in newly diagnosed Glioblastoma multiforme (GBM). This trial has completed its enrolment. Northwest Biotherapeutics’ is pursuing completion of the current Phase III trial of DCVax-L for Glioblastoma multiforme brain cancer and pursuing Phase II combination trials of DCVax-L and checkpoint inhibitor drugs. This includes the Phase II trial of DCVax-L and Pembrolizumab (Keytruda) for colon cancer that was previously announced.

The Company earlier received clearance from the Food and Drug Administration (FDA) for a 612-patient Phase III trial in prostate cancer. It received approval in Germany of a five-year Hospital Exemption for the treatment of all gliomas (primary brain cancers) outside the clinical trial.

Northwest Biotherapeutics is also pursuing a Phase I/II trial with DCVax-Direct for all kinds of inoperable solid tumor cancers. It has completed the 40-patient Phase I portion of the trial. It is preparing the Phase II portion. It earlier conducted a Phase I/II trial with DCVax-L for metastatic ovarian cancer in association with the University of Pennsylvania.

Additionally, Northwest Biotherapeutics’ product candidates include DCVax-Prostate. The design of this product is purposely for late stage, hormone independent prostate cancer. The Company has developed a DCVax product line using a particular proprietary antigen — PSMA (Prostate Specific Membrane Antigen). It is found on essentially all late stage (hormone independent) prostate cancer.

The PSMA is produced by way of recombinant manufacturing methods. It is then combined with the fresh, personalized dendritic cells to make DCVax-Prostate.

Recently, Northwest Biotherapeutics announced that its Chief Executive Officer, Ms. Linda Powers, increased her funding to the Company by $1 million, reaching a total of $5.4 million this year to date. On April 26, 2018, Northwest Biotherapeutics and Ms. Powers entered into a note and loan agreement for an additional loan of $1.0 million by Ms. Powers to the Company on the same terms as her previous funding, as earlier reported in March. 

Northwest Biotherapeutics, Inc. (NWBO), closed Tuesday's trading session at $0.2124, up 4.58%, on 1,040,871 volume with 153 trades. The average volume for the last 60 days is 1,247,842 and the stock's 52-week low/high is $0.1401/$0.398.


Airborne Wireless Network (ABWN)

Epic Stock Picks,, Penny Stock 101, StockRockandRoll, Penny Stock Craze, Penny Stocks Finder, OTCBB Journal, Stock Commander, Profitable Trader Authority, Damn Good Penny Picks, Penny Picks, Beacon Equity Research, Broad Street, and SuperStockTips reported earlier on Airborne Wireless Network (ABWN), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Airborne Wireless Network’s mission is to be a high-speed broadband internet pipeline to improve coverage connectivity now lacking. Its intention is to create a high-speed broadband airborne wireless network through linking commercial aircraft in flight. Each aircraft participating in the network will act as an airborne repeater or router, sending and receiving broadband signals from one aircraft to the next. This will create a digital superhighway in the sky. Airborne Wireless Network has its head office in Simi Valley, California.

Airborne Wireless Network has completed its acquisition of Patent Number US 6,285,878 B1 and the Trademark "Infinitus Super Highway". These acquired assets serve as a blueprint and road map for it to develop its "Airborne Wireless Network”.

Concerning its Wholesale Carrier Network, the Company’s plan is to use commercial aircraft as “mini-satellites”. Its primary target customer-base will be international data and communications service providers. Airborne Wireless Network’s system is to operate in a safe and controlled environment, usually between 20,000 and 40,000 feet (6,000-12,000 m).

The Company is developing a completely meshed network. In a completely meshed network, signals come in from numerous directions. The system will route signals around any obstructions. Fundamentally, it is a virtual airborne Worldwide Web. Because it is a meshed network, it is comparable to a web where all nodes are connected through many links.

Airborne Wireless Network will act as a wholesale carrier with target customers. The Company believes that its network, upon development, should provide low cost, high-speed connectivity to rural areas, island nations, ships at sea, oil platforms, in addition to connectivity to commercial and private aircraft in flight.

In January of this year, Airborne Wireless Network announced that on December 26, 2017, it entered into a service agreement with iNTELLICOM Technologies, Inc. to support the development and advancement of its Infinitus Super Highway™.

This past March, Airborne Wireless Network announced that on March 6, 2018 it entered into an Agreement with South Bay Aviation (Torrance, California based), for two airplanes for the upcoming second flight test of the Infinitus Super Highway network. The Company looks to expand on its initial RF proof of concept test that was completed in May 2017 using two Boeing 767-300ER aircraft and a mobile mast imitating a ground station.

Also in March, Airborne Wireless Network announced that on March 26, 2018 it applied with the FAA (Federal Aviation Administration) for experimental operating certificates for each flight test demonstration aircraft. Upon approval, these applications will allow for the modification and installation of the Infinitus Superhighway RF and Optical components on each of the two Cessna aircraft Airborne Wireless Network has arranged for use in connection with its upcoming demonstration tests of Infinitus.


Airborne Wireless Network (ABWN), closed Tuesday's trading session at $0.52, down 8.77%, on 273,497 volume with 171 trades. The average volume for the last 60 days is 251,268 and the stock's 52-week low/high is $0.51/$3.12.


Organigram Holdings, Inc. (OGRMF)

Wealth Daily, Cannabis Financial Network News, CFN Media Group, InvestorPlace, and Money Morning reported previously on Organigram Holdings, Inc. (OGRMF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Organigram Holdings, Inc.’s focus is on producing the highest quality, condition specific medical marijuana for patients in Canada. The Company’s wholly-owned subsidiary, Organigram, Inc, is a licensed producer of medical marijuana in Canada. Organigram’s head office, production facility, and Research and Development (R&D) are in Moncton, New Brunswick. The Company lists on the OTC Markets Group’s OTCQB.

Organigram Holdings is regulated by the Access to Cannabis for Medical Purposes Regulations (ACMPR). All of its products are manufactured under strict controls and in conformance with the Good Production Practices of the MMPR, and the security directives as defined by the Office of Controlled Substances. All products are lab tested before packaging and sale.

Organigram Holdings has collaborations with healthcare experts and academic institutions. It invests in medical education, outreach, and and research for the use of cannabinoids as a first line of treatment.

The Company provides a varied array of genetics and product types. These cater to the individual needs of each client. Organigram offers a reliable supply of premier quality, industry-leading strains to match individuals’ personal requirements.

Organigram is undergoing a production-facility expansion. The expansion will more than triple the size of its operations. The multi-million-dollar project will meet the increasing needs of its medical patient base, and also prepare the Company for the legal, adult-recreational marijuana market. The highlights of the Company’s plans include the addition of approximately 140 new employees by the end of this year.

The Company’s plans also include a production-capacity increase from roughly 5,200 kilograms (kg) annually to more than 25,000 kg annually. Plans also include the acquisition of a third building at 55 English Drive for future expansion, next to the current campus.

Earlier in May, Organigram Holdings announced it entered a non-binding term sheet to acquire up to 25 per cent of alpha-cannabis Pharma GmbH (Alpha-Cannabis Germany [ACG]) located in Stadthagen, Germany. Upon the agreement being final, Organigram will provide ACG with dried cannabis flower and sweet leaf for conversion into extracts for the escalating German medical cannabis market.

In addition, the parties anticipate entering into an agreement wherein Organigram will have an option to purchase pure synthetic CBD isolate from ACG. The parties anticipate jointly submitting for future licenses available to supply medical cannabis in the German market.

Last week, Organigram Holdings announced that Health Canada issued the Company a License for Controlled Drugs and Substances (Dealer's License) making Organigram a "Licensed Dealer". Mr. Greg Engel, Chief Executive Officer of Organigram Holdings said, "The Dealer's License will allow us to put our plans into action. Now that we have our Dealer's License in hand, we'll be aggressively moving forward on plans for alternative forms and partnerships to fully maximize the value of our planned production of over 113,000 kg of cannabis through 2020."

Furthermore, Organigram announced last week that it received a "Permit to Export Cannabis" from Health Canada. This will allow the Company to commence its first international shipments.

Organigram Holdings, Inc. (OGRMF), closed Tuesday's trading session at $3.85, down 3.51%, on 529,565 volume with 938 trades. The average volume for the last 60 days is 235,434 and the stock's 52-week low/high is $1.49/$4.56.


Noble Roman's, Inc. (NROM)

>Wall Street Resources, TaglichBrothers,, FeedBlitz, The Bowser Report, StockOodles, and SmallCapVoice reported on Noble Roman's, Inc. (NROM), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Noble Roman's, Inc. sells and services franchises and licenses for non-traditional foodservice operations and stand-alone take-n-bake locations. Its business model comprises three growth venues. These are Grocery Take-n-Bake Licensing; Non-Traditional Franchising; and Stand-Alone Franchising. It franchises and licenses under the Noble Roman’s Pizza, Noble Roman’s Take-N-Bake, Tuscano’s Italian Style Subs, and Noble Roman's Craft Pizza & Pub (CPP) trade names. Noble Roman’s is based in Indianapolis, Indiana.

Noble Roman’s has awarded franchise and/or license agreements in all 50 U.S. States plus Washington, D.C. Moreover, it has awarded franchise and/or license agreements in Canada, Puerto Rico, the Bahamas, Italy, and the Dominican Republic.

The Company’s Craft Pizza & Pub (CPP) features two styles of hand-crafted, made-from-scratch pizzas with a selection of 40 different toppings, cheeses, and sauces. Additionally, beer and wine are featured, with 16 different beers on tap.

Concerning Non-Traditional Venues, these are typically located in a host facility whose primary business is other than foodservice. These facilities can add pizza-focused foodservice as a Revenue Center; as a Facility Draw; and as an Employee Benefit.

Regarding Stand-Alone Venues, these are traditional pizzeria locations and Take-n-Bake locations. There is a merging over time between the kinds of Stand-Alone Venues: Live Yeast Dough; Hand-Rolled Breadsticks; and Baking Services.

Grocery Take-n-Bake Licensing involves licensing to sell Noble Roman’s Pizza. This is a component program using Noble Roman’s ingredients, in which delis assemble pizzas from standard Noble Roman’s ingredients.

The first Noble Roman's CPP opened on January 31, 2017 in Westfield, Indiana in the Monon Marketplace on Main Street/Highway 32 across from Grand Park.
On April 18, 2018, Noble Roman's announced that its Westfield, Indiana location had record sales for the most recent week and also the single highest sales day for the nearly 15 months it has been open.

Mr. Scott Mobley, Noble Roman's President and Chief Executive Officer, said, ''We are extremely encouraged with the continued development of our Westfield, Indiana Craft Pizza & Pub location. As the first to pass its one-year anniversary mark, setting new sales records is a great achievement. We believe this demonstrates the strength of the concept overall, and we are proud of the management team and employees in place as we celebrate their accomplishment.”

During Q1 2018, Noble Roman's signed a lease for its fourth company-operated Craft Pizza & Pub location in Carmel, Indiana. The expectation is that it will open to the public on May 29, 2018. The three current Craft Pizza & Pub locations all continue to surpass Management's pre-opening sales expectations.

During Q1 2018, Noble Roman’s refocused its efforts on selling franchises for non-traditional franchised locations. The Company has sold 18 such franchises between January 1, 2018 and May 12, 2018.

Noble Roman's, Inc. (NROM), closed Tuesday's trading session at $0.61, up 2.01%, on 56,100 volume with 8 trades. The average volume for the last 60 days is 25,825 and the stock's 52-week low/high is $0.38/$0.87.


The QualityStocks Company Corner

Medical Cannabis Payment Solutions (REFG)

The QualityStocks Daily Newsletter would like to spotlight Medical Cannabis Payment Solutions (REFG).

Cannabis-focused financial services company Medical Cannabis Payment Solutions (OTC: REFG), through its Green payment processing system, provides dispensaries operating in state-legalized cannabis markets a proprietary, full scale financial program. To view the full article, visit: Also today, CannabisNewsWire released a report on the company detailing how REFG has expanded its role in the cannabis market through its acquisitions of Colorado-licensed SpeedyGrow and organic soil accelerator SpeedyVeg, with its proprietary formula geared to maximize plant yield (

Medical Cannabis Payment Solutions (REFG), headquartered in Cheyenne, Wyoming, is a first-tier merchant processing cannabis industry pioneer, offering one of the first and only comprehensive card processing operations of its kind to serve the state-sanctioned medical marijuana industry. The company’s state of the art system, which also tracks sales and tax collection, and eliminates the need to deal in cash-only transactions.

Through its robust, closed-loop merchant processing system, the company’s unique “StateSourced” proprietary system enables authorized operation under FinCEN parameters and complies with all regulatory frameworks. StateSourced is tailored to deliver full-spectrum merchant processing services, providing the convenience of modern commercial card processing resources and making it the first operation of its kind geared to the legal cannabis industry.

StateSourced is not a prepaid or gift card, which is an important variable for merchants since standard banking institutions have not offered this form of payment processing to the legal cannabis industry. Federal law still considers marijuana illegal under the Controlled Substances Act, although 29 states and the District of Columbia have legalized the plant either for medicinal or recreational uses or both. This restriction has kept financial institutions at bay since most banks are federally insured and haven’t been inclined to venture into the nascent industry.

Medical Cannabis Payment Solutions is able to offer its StateSourced card on a state-by-state basis where the card can be used in purchasing product from a legal, authorized vendor, providing a much-needed option for consumers and businesses alike. In another first, the company is collaborating with First Bitcoin Capital Corporation to integrate First Bitcoin’s cryptocurrency ($Weed) with Medical Cannabis Payment Solutions’ StateSourced payment gateway. This collaboration will allow state-licensed marijuana establishments across the nation to accept both StateSourced debit cards and cryptocurrencies such as WeedCoin and Bitcoin.

Medical Cannabis Payment Solutions president and CEO Jeremy Roberts and his executive team are working with state lawmakers to introduce legislation in an effort to address the growing problems in banking for the medical cannabis industry. For companies in the emerging legal cannabis industry, where retail and non-retail transactions such as vendor payments and payroll are almost exclusively paid for with cash, the solutions offered by StateSourced can help businesses avoid the inherent risks associated with a cash-intensive sector. Medical Cannabis Payment Solutions has also signed its first StateSourced contract with a Las Vegas-based vertically integrated marijuana establishment.

“We’ve completed our transition from development stage to revenue stage,” says Roberts. “We have just started our business development efforts and the market is responding very well. We anticipate having many more, similar releases.”

Medical Cannabis Payment Solutions provides end-to-end management across multiple systems for medicinal marijuana operations. The company solves the fragmentation problem experienced by many of these rapidly growing companies by identifying tools that are important to dispensaries and customizing those tools to meet the specific needs of this unique industry.

Medical Cannabis Payment Solutions (REFG), closed the day's trading session at $0.056, up 4.67%, on 3,635,809 volume with 265 trades. The average volume for the last 60 days is 372,486 and the stock's 52-week low/high is $0.0161/$0.115.

Recent News


Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF)

The QualityStocks Daily Newsletter would like to spotlight Global Hemp Group, Inc. (GBHPF).

MARIJUANA COMPANY OF AMERICA INC. (“MCOA” or the “Company”) (OTC:MCOA), an innovative hemp and cannabis corporation, is pleased to provide an update on its New Brunswick Hemp Project with joint venture partner, Global Hemp Group Inc. (CSE:GHG) (OTC:GBHPF) (FRANKFURT:GHG) (the “Partners”).

Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTCQB: GBHPF), headquartered in British Columbia, Canada, is a publicly traded company founded in 2014. Global Hemp Group is focused on acquiring and developing a strategic portfolio of like-minded companies that believe in the significant potential of the industrial hemp plant. Global Hemp Group’s focused on attracting joint venture partners across all sectors of the industrial hemp industries with the commitment to improve quality of life by researching, developing and distributing sustainable materials, products and services produced from hemp.

The company’s mission is to build a strategic portfolio of hemp-based companies that operate synergistically to consistently deliver a solid ROI to its shareholders. Global Hemp Group has established the concept of Hemp Agro-Industrial Zone (HAIZ) ( in order to build cooperative mechanisms across industrial sectors with a focus on different parts of the hemp plant. Under the HAIZ strategy, Global Hemp Group brings together capital, farmers and labor in an effort to build a “soil-to-shelf” portfolio of complimentary companies and joint venture partners in the global hemp industry.

Global Hemp Group has chosen to only work with suppliers of high quality, sustainable raw materials and finished products derived from the hemp plant. Among the leading industries utilizing industrial hemp’s exceptional properties is the automotive sector, building materials market, bio-composites, energy-related markets, super-foods, nutritional supplements, nutraceuticals and the cannabinoid markets. Guided by the principal theme of “global environmental stewardship,” Global Hemp Group focuses on the key concepts of sustainability and social responsibility in all its endeavors.

Global Hemp Group’s joint venture with publicly traded Marijuana Company of America on hemp cultivation trials in 2017, designed to develop commercial hemp production on the Acadian peninsula of New Brunswick, Canada, for the first time in 20 years, was a great success. The partners are preparing for the upcoming changes in Canada’s cannabis legislation that will permit cannabinoid extraction from industrial hemp. Farmers have already been recruited to plant a minimum of 125 acres of industrial hemp for the 2018 growing season, with the goal of increasing the acreage under cultivation to 1,000+ acres by year three of the joint project. Global Hemp Group is preparing an application for a processing license to extract cannabidiol (CBD) and other cannabinoids from the upcoming industrial hemp crop. Discussions are also underway with potential processing partners for the extraction of cannabinoids and straw processing for building materials for the upcoming harvest in October 2018, with a longer term plan to establish permanent processing facilities by October 2019.

Global Hemp Group is led by Charles Larsen as its president, CEO and chairman of the board. Larsen’s more than 30 years of experience working in government, public, private and startup companies as an executive manager includes being the founding president of Medical Marijuana, Inc., the first public company in the Cannabis space. Larsen is also a founder and current director of Marijuana Company of America, Inc., and has been actively involved in the cannabis and hemp industry for nearly a decade. Larsen is joined by Curt Huber, who serves as CFO and director. Huber is an independent corporate and financial consultant with more than 25 years of experience in all facets of public companies among many different sectors including mining, oil and gas, and technology.

Also joining the management team as director is Dr. Paul T. Perrault, an agricultural economist trained in cooperative development and in rural development. Perrault’s experience includes years of consulting on rural development projects introducing new crops in several developing countries and strengthening agricultural research organizations, principally in Africa. Jeff Kilpatrick also serves as a director and is currently a program supervisor of Alachua County Department of Court Services in Gainesville, Florida. Kilpatrick, who spent 21 years in the U.S. Coast Guard, is a member of LEAP – Law Enforcement Against Prohibition – and is president elect for the National Association of Pretrial Services Agencies (NAPSA).

Global Hemp Group’s business philosophy is “A healthier future through sustainable business strategies.“

Global Hemp Group, Inc. (GBHPF), closed the day's trading session at $0.15, up 11.97%, on 960,963 volume with 232 trades. The average volume for the last 60 days is 173,413 and the stock's 52-week low/high is $0.0115/$0.316.

Recent News


First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF)

The QualityStocks Daily Newsletter would like to spotlight First Cobalt Corp. (FTSSF).

Demand for high-efficiency batteries is leading to growth in the cobalt industry, but new ventures are threatened by the Democratic Republic of Congo’s (DRC) dominance in mining and China’s in processing. Some companies are now trying to break this stranglehold, with First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) establishing the largest integrated operation in North America.

First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF), with headquarters in Canada, is the largest land owner in the Cobalt Camp in Ontario with control of over 10,000 hectares (nearly 25,000 acres) of prospective land and 50 historic cobalt/silver mines. The company’s assets include a mill and the only permitted cobalt extraction refinery in North America capable of producing battery material, providing an integrated solution for cobalt projects. First Cobalt began drilling in the historic Cobalt Camp in 2017 and seeks to build shareholder value through new discovery and growth opportunities.

First Cobalt’s 2018 $C7 million drilling program, which includes testing different styles of mineralized areas throughout the Cobalt Camp in more than 10 past-producing mines known to contain cobalt, is a significant expansion over its 2017 exploration activities. The company received positive test drill results from the Bellellen mine location, with early results confirming the presence of high-grade cobalt and nickel, prompting First Cobalt to increase its drilling program at that site. A prospecting sampling program of existing muckpiles around the camp’s historic mines, trenches, pits and surrounding bedrock could provide an early production scenario.

First Cobalt Corp. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world’s current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

First Cobalt is embracing innovation in the mining sector, utilizing a digital compilation of 100-plus years of mining and geological data spanning the historically prolific Cobalt Mining Camp’s lifespan. First Cobalt’s management team is also assessing the ability of artificial intelligence to accelerate the discovery cycle. As a member of the Mineral Exploration Research Centre (MERC) and Metal Earth Project, First Cobalt conducts regional geophysical surveys for geological interpretation of structures controlling cobalt-silver mineralization.

The company’s clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, First Cobalt Corp. and its mining interests are primed for success.

First Cobalt Corp. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance.

First Cobalt Corp. (FTSSF), closed the day's trading session at $0.62, up 6.35%, on 75,065 volume with 49 trades. The average volume for the last 60 days is 122,507 and the stock's 52-week low/high is $0.3148/$1.3041.

Recent News


The Green Organic Dutchman (TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (TGODF).

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) is pleased to announce that the Company has entered into an exclusive agreement with CBx Enterprises LLC for the licensing of the Evolab and CBx Sciences brands and proprietary technologies and formulations within Canada and other international jurisdictions outside of the USA.

The Green Organic Dutchman (TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at

The Green Organic Dutchman (TGODF), closed the day's trading session at $3.0862, off by 5.62%, 321,978 volume with 492 trades. The average volume for the last 60 days is 24,842 and the stock's 52-week low/high is $2.784/$3.775.

Recent News


Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)

The QualityStocks Daily Newsletter would like to spotlight Foresight Autonomous Holdings Ltd. (FRSX).

Self-driving cars are already appearing on our roads. One of the main technological barrier holding them back from full use is the creation of effective sensor systems, and several companies are conducting specialist research in this area. Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) has created a unique system that combines infrared and visible light cameras in stereo technology that can detect obstacles under all weather and lighting conditions.

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.

Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.

The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.

Foresight has developed three main products:

  • QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
  • Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
  • Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.

In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.

Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.

Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.

Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.

Foresight Autonomous Holdings Ltd. (FRSX), closed the day's trading session at $2.89, off by 1.20%, on 57,557 volume with 176 trades. The average volume for the last 60 days is 32,423 and the stock's 52-week low/high is $0.0075/$0.105.

Recent News


Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

Marijuana Company of America, Inc. (OTC:MCOA) was highlighted today in an article discussing how the multi-billion dollar cannabis industry is receiving a big push from advanced legislation efforts throughout North America, especially in Canada, where the substance will be legal for recreational use within months. Also today, NetworkNewsWire released a report on the company detailing an update on from MCOA on its New Brunswick Hemp Project with JV partner Global Hemp Group (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF). Additionally, CannabisNewsWire released a report on the company detailing how MCOA is advancing CBD hemp farming at its joint venture (JV) with Global Hemp Group, Inc. on a 109-acre farm in Scio, Oregon.

Marijuana Company of America Inc. (MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.032, up 2.89%, on 6,735,847 volume with 340 trades. The average volume for the last 60 days is 5,079,215 and the stock's 52-week low/high is $0.0181/$0.0728.

Recent News


Aftermaster, Inc. (OTCQB: AFTM)

The QualityStocks Daily Newsletter would like to spotlight Aftermaster, Inc. (AFTM).

Aftermaster (OTCQB: AFTM) is directed by a group of seasoned audio engineers and music industry experts specializing in the development of proprietary audio technologies and products. To view the full article, visit:

Aftermaster, Inc. (OTCQB: AFTM), with offices in Scottsdale, Arizona, and Hollywood California, is an award-winning, leading-edge audio technology company that specializes in the development of proprietary and groundbreaking audio technologies and products. The company also operates world-class mastering and recording studios located in the heart of Hollywood, California, in the famous Crossroads of the World complex along Sunset Boulevard.

Aftermaster and its subsidiaries are engaged in the development and commercialization of proprietary (patents issued and pending), leading-edge audio and video technologies for professional and consumer use including the award-winning AfterMaster® audio technology, ProMaster™ and Aftermaster Pro™. Aftermaster is unique in the audio world because its team has produced, engineered and mastered more hit records than any audio company in the world. The Aftermaster team knows what sounds right and the Company holds a unique position in the world of audio technology.

The Company’s underlying technology, Aftermaster audio, delivers an audio experience unrivaled by any audio company. It brings an unprecedented new quality level to consumer audio by offering unparalleled clarity, depth, fullness and a significant volume increase to audio recordings without distortion or altering the original recording. Its versatility and smart processing characteristics make it effective across a broad range of applications from consumer electronics to industrial applications.

The Company also operates Aftermaster Recording and Mastering Studios which include the renovated production facilities of legendary director Alfred Hitchcock and the iconic recording studios of Crosby, Stills and Nash.

Aftermaster Labs maintains five primary business units: Aftermaster proprietary semiconductor chip and software for OEM licensing, proprietary consumer electronics, professional music mastering, online mastering, recording and mixing at its Aftermaster Recording and Master Studios, and Audio Consulting services. The Aftermaster semiconductor chip and software is used for embedding in consumer products, Aftermaster-developed and branded consumer and professional electronic products, ProMaster on-line music mastering for independent music artists and in-studio professional music mastering services.

Aftermaster has increasingly attracted interest from some of the music industry’s leading audio companies. A newly expanded partnership with TuneCore, the leading digital music distribution and publishing administration provider, gives TuneCore members access to Promaster through its instant mastering service which offers audio mastering of unparalleled quality at the click of a button. The Company also recently entered into a licensing agreement with Muzik headphones for use of its Aftermaster chip in their new headphone line.

The company’s first groundbreaking consumer product – the Aftermaster Pro – is designed to solve the universally widespread problem of poor, variable audio levels of television audio. Aftermaster Pro, which is smaller than an iPhone, masters and remasters inconsistent TV audio in real-time, creating an audio experience that offers clear, full-bodied depths of sound and most importantly, overall balanced audio. The Aftermaster Pro virtually eliminates the need to adjust TV volume to hear dialogue or to reduce the level of loud special effects. The Aftermaster Pro sells for $179 and is enjoying strong growth in sales to over 65 countries.

With the Company’s Promaster, state-of-the-art proprietary algorithms, artists receive four CD quality mastered versions of their track including “Powerful,” “Radio Ready,” “Bass Enhanced,” and “Vocal Enhanced.”  TuneCore artists have access to exclusive pricing on the Promaster pay-as-you-go instant mastering, as well as unlimited monthly and annual subscriptions. Aftermaster also holds a license agreement with headphone manufacturer, Muzik, Inc., for the use of Aftermaster’s patented audio remastering and audio enhancement technology.

Aftermaster won three Envisioneering Innovation and Design Awards at the 2016 Consumer Electronics Show in Las Vegas for both its Aftermaster TV device and its BelaSigna 300 processor semiconductor chip created through a partnership with ON Semiconductor. Aftermaster was also named an honoree for its ProMaster audio technology.

Aftermaster Audio Labs is led by a group of world-class audio engineers and music industry veterans who have been involved with the development and implementation of countless successful proprietary audio technologies and products.

The Team

Aftermaster co-founder and CEO Larry Ryckman is an award-winning entertainment and technology executive with over 25 years of achievements in the music and entertainment industries.

Shelly Yakus, co-founder and chief engineer at Aftermaster Audio Labs, is a renowned music producer, audio engineer/mixer and is widely considered the best engineer and mixer in the music industry.

Justin Timberlake, a Grammy and Emmy award-winning singer/songwriter/producer and actor, is a co-owner of Aftermaster Audio Labs, Inc. Timberlake is widely considered to be one of pop culture’s most influential entertainers in the world.

Peter Doell is one of the best-known mastering engineers in the world with over 35 years of experience mastering and engineering hundreds of chart-topping records, film scores and TV spots. Rodney Jerkins is an 8-time Grammy Award winning music producer/songwriter and considered to be one of the most influential and successful producers in the music industry.

Paul Wolff is a senior engineer and product development consultant at Aftermaster Audio Labs. Wolff has been involved in the professional music and audio industries as an audio engineer and product designer and manufacturer of professional audio products for more than 35 years.

Thousands of hours of testing millions of songs and audio sources of all types have been processed using Aftermaster’s award-winning technology and the results speak for themselves with platinum records, numerous strategic partnerships, and overwhelming industry support.

Aftermaster, Inc. (AFTM), closed the day's trading session at $0.062, up 0.81%, on 244,500 volume with 11 trades. The average volume for the last 60 days is 379,455 and the stock's 52-week low/high is $0.035/$0.31.

Recent News


Pivot Pharmaceuticals Inc. (PVOTF)

The QualityStocks Daily Newsletter would like to spotlight Pivot Pharmaceuticals Inc. (PVOTF).

Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) is pleased to announce that it is has initiated development of CBD and THC additives and formulations for the multi-billion dollar beverage industry using its patented Ready-To-Infuse-Cannabis ("RTIC") Powder and Solmic Micelle water-soluble technologies. The development program will be led by Pivot's Executive Director of Formulations, Dr. Leonid Lurya, at the Company's contract lab in Israel.

Pivot Pharmaceuticals Inc. (OTCQB: PVOTF), based in Vancouver, Canada, is an emerging biopharmaceutical company engaged in the development and commercialization of pharmaceuticals and nutraceuticals that provide novel treatments for unmet healthcare needs. Pivot’s recent acquisition of BiPhasix ™ Transdermal Drug Delivery technology for the delivery of cannabinoids (CBD) to patients provides the answer for an age-old problem associated with cannabinoid-based therapies: the lack of a robust smoke-less delivery mechanism.

Research into the bioavailability of cannabinoid-based therapeutics shows that rates of absorption vary greatly between smoking cannabis to an orally-consumed product, with a difference noted even between individuals. Cannabinoids are degraded in the stomach and smoking may not appeal to patients for health or lifestyle reasons. Topical delivery, while a better alternative, has suffered from weak formulation issues. Transdermal cannabinoid delivery, on the other hand, could provide a better alternative route since it reduces side effects and bypasses other absorption issues. In addition, transdermal delivery provides the benefit of enabling patients to access a steady stream of medication over a prolonged period with fewer side effects.

Pivot Pharmaceutical’s newly created subsidiary, Pivot Green Stream Health Solutions Inc. (“Pivot Green Stream”), will focus on improving the bioavailability of cannabinoid-based and pharmaceuticals. BiPhasix™ has been tested in FDA and EMA approved human clinical trials, which have shown the delivery system enhances the bioavailability of many drugs and improves clinical outcomes. Pivot Green Stream is tasked with developing several natural health products containing cannabinoids (CBD) that can receive a Health Canada Natural Health Product (NHP) designation. This marketing method ensures a shorter development cycle and faster revenue generation opportunities.

Pivot Pharmaceuticals Inc., which has positioned itself as a growing and crucial vertical in the cannabis industry, represents a compelling opportunity in the biotechnology field. The company’s plans include working with Licensed Producers (LP) and Licensed Dealers (LD) to bring newer therapies to patients. The company has also applied to list on the Canadian Stock Exchange (CSE).

The global medical marijuana market is expected to reach a value of $55.8 billion by 2025, according to a new report by Grand View Research, Inc. The growing number of states and countries gaining approval for using cannabis in therapeutic applications is expected to continue driving the market forward.

Pivot Pharmaceuticals has assembled a highly experienced management team, bringing together a wealth of clinical, commercial, product development and financial experience. Among the many healthcare targets in Pivot’s pipeline are cancer supportive care, pain and inflammation, women’s sexual dysfunction, dermatology and eye disease.

Pivot Pharmaceuticals Inc. (PVOTF), closed the day's trading session at $0.5482, off by 0.33%, on 354,070 volume with 143 trades. The average volume for the last 60 days is 113,165 and the stock's 52-week low/high is $0.047/$2.46.

Recent News


Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF)

The QualityStocks Daily Newsletter would like to spotlight Lithium Chile Inc. (LTMCF).

Almost everyone is aware of the tear that lithium stocks have been on over the last couple years. given the location and value of its assets, a prospective junior miner, Lithium Chile Inc. (TSX.V: LITH) (OTCQB: LTMCF) (LTMCF Profile), may possibly outperform any other lithium player this year. However, given the location and value of its assets, a prospective junior miner, Lithium Chile Inc. (TSX.V: LITH) (OTCQB: LTMCF), may possibly outperform any other lithium player this year.

Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF), headquartered in Canada, is advancing one of the largest lithium-rich exploration portfolios in Chile consisting of more than 148,000 hectares covering sections of 13 salars or mineral salt flats and one laguna complex. The company’s wholly owned premier properties include 66 square kilometers on the Salar de Atacama, Chile’s largest mineral salt flat which hosts the world’s highest concentration of lithium brine production and is currently the source of about 35 percent of the world’s lithium production. Lithium Chile also owns a significant copper/gold/silver property portfolio consisting of 28,184 hectares over six different properties.

Lithium Chile’s portfolio in the heart of Chile’s lithium-rich salars includes Salar de Coipasa, Salar de Helados, Salar de Atacama, Salar de Turi Salar de Ollague and Salar de Talar. Surface and near surface salt and brine sampling programs on all properties has been completed. To date, samples of high-grade, near-surface lithium brines at each of these projects are showing excellent chemistry of lithium to potassium and lithium to magnesium ratios. Good chemistry is important as it reduces your overall cost of production. Recent geophysical surveys including T.E.M have been completed on 5 of 6 priority targets and data collected to date has been extremely encouraging.

Lithium Chile has identified multiple high-priority brine target areas at its Atacama and Ollague lithium project areas. These areas display the same geophysical characteristics as the lithium-rich aquifers at Salar de Atacama, home to the world’s largest and highest-grade lithium brine producers. Spanning an area of 1,200 square miles, Salar de Atacama is the world’s third largest salt flat behind Salinas Grandes in Argentina and El Salar de Uyuni in neighboring Bolivia. Exploration drilling and resource definition drilling for these target areas are planned for 2018.

“We are delighted with the discovery of such impressive drill target areas at Atacama and Ollague. The results also follow the recent discovery of a 60km2 target area at another of our top Chilean projects – Helados – where we hope to drill in the second quarter of 2018,” stated President and CEO Steve Cochrane. “We have an aggressive multi-project drill program planned for this year, which includes all three of these exciting projects and we look forward to sharing drill results as they come through.”

Global demand for lithium-ion batteries is expected to surpass US$53 billion by 2024 as governments around the world aggressively seek to ban gas-powered vehicles and major automakers invest billions in new technology and electric vehicles powered by lithium-ion batteries. Chile’s mining-friendly jurisdiction offers Lithium Chile a clear, streamlined permitting process that significantly lowers the cost of lithium production to around $1,800/ton as compared to Australia’s $5,000/ton.

Lithium Chile is led by an experienced team with strong Chilean connections. Cochrane’s 36 years of investment industry experience have primarily been focused on the mining sector. During this time, he raised more than US$500 million for a variety of small cap public companies in various businesses and industry sectors including mining.

Terry Walker, P.Geol., vice president of exploration and chief geologist, is a highly experienced geologist. He has spent over 25 years in Chile’s mining industry and is well connected throughout the sector. Walker is co-founder of GeoServicios Piedra Dorada, an exploration and development services company focused on Latin America. He is a Qualified Person for the North American and Australian stock exchanges.

Lithium Chile is well funded and driven by a top-tier team with more than 100 years of combined experience in financing, mining exploration and development in the natural resources sector.

Lithium Chile Inc. (LTMCF), closed the day's trading session at $0.69173, off by 0.40%, on 32,800 volume with 6 trades. The average volume for the last 60 days is 1,003 and the stock's 52-week low/high is $0.6599/$0.9021.

Recent News



The QualityStocks Daily Newsletter would like to spotlight EVIO, Inc. (EVIO).

EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry, recently announced that it has expanded into the Southern California cannabis market through the execution of a long-term lease for a 2,700 square foot facility in Los Angeles. To view the full press release, visit:

EVIO, Inc. (EVIO), via the EVIO Labs division, is the nation’s leading provider of accredited analytical testing, scientific research and advisory services to the regulated cannabis industry. EVIO Labs provides state-mandated ancillary services that are required to ensure the safety and quality of the nation’s cannabis supply. EVIO Labs has performed over 50,000 tests during the past two years and grown from one laboratory in Oregon to nine labs spanning California, Oregon, Colorado, Massachusetts and Florida.

EVIO Labs is driving the cannabis testing industry by providing clients nationwide with consistent high-quality cannabis analytical services backed by quality control assurances. The company also provides advisory services that help cannabis producers and retailers enhance production processes, achieve regulatory compliance and meet quality goals.

EVIO Labs is on track to open 18 laboratories by the end of 2018 at locations around the United States. The Oregon-based company provides analytical services that include testing cannabis and industrial hemp flower, extracts and infused products. The labs specialize in performing the following tests:

  • Cannabinoid analysis, which properly characterizes the many primary cannabinoids found in cannabis including THC, CBD, and several other cannabinoids.
  • Terpene analysis, which identifies the aromatic compounds of the plant (terpene), which can help identify the therapeutic potential of a cannabis flower or extract.
  • Moisture content and water activity, which measure the moisture levels of dried cannabis and are indicators of microbiological growth potential.
  • Pesticide residue analysis of over 100 different pesticides, herbicides, fungicides, growth regulators and other agrochemicals that may be present on cannabis.
  • Detection of harmful residual solvents left behind in the cannabis extract production process.
  • Microbial testing screen for bacterial and fungal contamination in cannabis and cannabis-infused products.
  • Detection of heavy metals including lead, cadmium, mercury, and arsenic.

EVIO Labs is rapidly becoming the nation’s leading cannabis biotechnology company. Led by a management team with extensive experience in designing and rolling out successful business ventures, product research and development, regulatory and compliance protocols, medical cannabis cultivation, production and analytical chemistry techniques, EVIO Labs is prepared to take advantage of today’s fastest growing industry.

EVIO, Inc. (EVIO), closed the day's trading session at $1.24, up 0.98%, on 72,153 volume with 104 trades. The average volume for the last 60 days is 76,806 and the stock's 52-week low/high is $0.47/$2.70.

Recent News


Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P)

The QualityStocks Daily Newsletter would like to spotlight Liberty Leaf Holdings Ltd. (LIBFF).

Liberty Leaf Holdings Ltd. (CSE: LIB, OTCQB: LIBFF and FSE: HN3P) is a Canadian-based, public company whose objective is to be at the forefront of the cannabis industry, accelerating vertically-integrated businesses within this rapidly growing sector.

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) is a publicly traded Canadian-based company with strategic investments in businesses that are established, revenue- producing players in the medicinal and recreational cannabis market. Liberty Leaf’s focus is to build and support a diversified portfolio of cannabis-sector businesses, including those involved in the cultivation and processing of legal medicinal and recreational cannabis, value-added CBD/THC pet products, and supply-chain products for this dynamic and fast-growing sector. Liberty Leaf provides funding, management, HR resources and marketing expertise to help companies thrive and accelerate growth.

Liberty Leaf’s leading investments to date include:

  • North Road Ventures – An emerging end-to-end distributor of cultivated and manufactured cannabis products to licensed legal retailers. North Road has updated its application for an Access to Cannabis for Medical Purposes Regulations (ACMPR) license to be distribution/sales-focused, making the company unique in the crowded field of other cultivation-based applicants. This forward-thinking initiative will help fulfill the anticipated increase in Canada’s recreational cannabis space once legalization takes effect in mid-2018. The submission includes a boost in product-vault capacity that will result in a five-fold increase in products available for distribution. Cannabidiol (CBD)-oil products are expected to account for 50 percent or more of projected sales.
  • Just Kush Enterprises – Liberty Leaf holds a 60 percent interest in Just Kush, a cultivator of premium, proprietary cannabis strains selected for different levels of CBDs and THCs. Just Kush’s cultivation facility is located near Oliver, British Columbia, and it currently controls a facility which holds a Medical Marihuana Access Regulations (MMAR) license. The company is also a late-stage applicant for an ACMPR license (Access to Cannabis for Medical Purposes Regulations), which will enable Just Kush to produce cannabis for the medicinal and recreational market.

Liberty Leaf is also an active partner with the following companies:

  • ESEV R&D – A privately owned, medical marijuana research and development company based in New York with clinical laboratories located in Israel. ESEV R&D, in collaboration with a leading clinical research organization in Israel, has launched a one-of-a-kind service for North American medical cannabis companies to organize and oversee clinical trials seeking to demonstrate the efficacy of medical cannabis products for specific medical conditions. Liberty Leaf has a three-year collaborative agreement with ESEV. Under that agreement, ESEV is researching the efficacy of CBDs in pets, with the 1st formulation trial targeting canine osteoarthritis, a medical condition that includes: hip dysplasia; elbow dysplasia; and hind-knee, also known as stifle, degenerative joint disease (DJD).
  • Blox Labs Inc. – A boutique technology development company focused on creating best-in-class software solutions driven by emerging trends in blockchain, smart contracts and decentralized application technologies. Liberty Leaf and Blox Labs are developing “cannaBLOX,” a blockchain-based smart contract supply chain management platform for the legalized cannabis industry. The cannaBLOX blockchain software will aim to ease and obliterate logistical bottlenecks, ensure product safety and quality of supply, minimize fraud and potential criminal activity, and assist with taxation and regulatory compliance across various levels of government within the legalized cannabis marketplace. To date, preliminary framework and analysis required for a cannaBLOX Whitepaper has been completed and a development team that specializes in blockchain and decentralized application technologies, including omni-language development in Ethereum and NEO, is now working on the project.

The company’s management team is led by President and Director William Rascan who has 25-plus years in the investment brokerage industry, most recently as a partner, senior investment advisor with Northern Securities. Rascan’s business experience ranges from active international trading clients to raising capital for junior mining companies on the TSX Venture Exchange.

Rascan is joined by CFO Jamie Robinson, a chartered accountant who specializes in accounting, auditing, and financial reporting under both IFRS and ASPE. Prior to joining Liberty Leaf, Robinson worked at Deloitte as a manager focused on publicly listed and private company audits, business review, performance enhancement engagements and restructuring proceedings.

Steven Feldman, who has more than 25 years of experience in the capital markets and was part of the original management team of SouthGobi Resources; and Doug Macdonell, a retired RCMP officer and recognized expert in the field of cannabis and cultivation, serve as company directors. Dr. Robert Jackman, who has worked closely with multiple clients in the medical cannabis and Natural and Non-prescription Health Products (NNHP) industries in North America, was recently appointed as scientific project manager/fulfillment.

Liberty Leaf’s advisory board includes international lawyer, writer and speaker Robert W.E. Laurie; Barinder Rasode, who currently serves as CEO of the National Institute for Cannabis Health & Education (NICHE); and Dr. Mary C. Fitzpatrick, B.S., D.V.M., whose primary focus is on helping companion animals live pain free in their senior years.

Liberty Leaf Holdings Ltd. (LIBFF), closed the day's trading session at $0.238, off by 11.82%, on 55,755 volume with 26 trades. The average volume for the last 60 days is 52,296 and the stock's 52-week low/high is $0.0091/$0.8074.

Recent News


The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.